Company Overview

TruoX Laboratories is a Montreal-based pharmaceutical quality control company specializing in small-molecule Chemistry and Microbiology testing.
Our mandate is to deliver analytical precision through validated systems, regulatory alignment, and lean operational design. The company was founded to address a critical gap in the Canadian analytical landscape — the lack of transparent, audit-ready laboratories integrating both traditional GMP discipline and modern digital infrastructure.

Mission

To modernize pharmaceutical quality control through precision analytics, validated software, and scientific integrity — ensuring every result is reproducible, traceable, and compliant with global standards.

Vision

To establish TruoX Laboratories as a benchmark for GMP analytical excellence in North America, evolving into a vertically integrated organization spanning quality control, automation software, and regulated manufacturing.

Corporate Structure

TruoX Laboratories operates as a privately held corporation incorporated in Canada under the name TruoX Pharmaceuticals Inc.
Our governance model emphasizes long-term stability and balanced equity distribution among the founding team, with the CEO retaining controlling interest to ensure mission continuity. The company’s executive functions are divided as follows:

  • Chief Executive Officer (CEO): Strategic leadership, compliance oversight, and corporate development.
  • Chief Operating Officer (COO): Process optimization, logistics, and resource management.
  • Chief Marketing Officer (CMO): Market positioning, investor relations, and communications.
  • Technical Advisors & Analysts: Senior chemists and technologists providing analytical, regulatory, and systems expertise.

Core Competencies

GMP-aligned analytical testing for small-molecule compounds.
Method validation, impurity profiling, and system suitability analysis.
Development of validated LIMS infrastructure (TruoX LIMS) for end-to-end data integrity.
Integration of automation, AI, and statistical process control to enhance throughput and compliance.

Quality and Compliance

TruoX adheres to the following frameworks and guidelines:

  • Health Canada GMP (C.02.001–C.02.029)
  • ICH Q7–Q10 for Quality Systems and Risk Management
  • GAMP 5 (2nd Edition) for Computerized System Validation
  • ALCOA+ for data integrity and traceability
  • CEPA, CNESST, and provincial EQA standards for environmental and occupational compliance

All internal systems are documented, version-controlled, and validated in accordance with industry best practices.
The long-term goal is certification under ISO 9001 and ISO 14000, followed by GMP establishment licensing.

Strategic Outlook

TruoX is currently in its pre-MVP stage, developing its proprietary LIMS and CSV documentation suite as the foundation for its future GMP analytical operations.
The company’s immediate objective is to achieve operational readiness for Phase I (QC Laboratory), followed by structured expansion into SaaS and manufacturing divisions.